233 related articles for article (PubMed ID: 30644528)
21. Survival Outcomes and Prognostic Factors of Dermatofibrosarcoma Protuberans: A Population-Based Retrospective Cohort Analysis.
Chen S; Xiong L; Zhao L; Li Y; Li L
Dermatol Surg; 2023 Sep; 49(9):825-831. PubMed ID: 37384896
[TBL] [Abstract][Full Text] [Related]
22. Dermatofibrosarcoma protuberans: a rare entity and review of the literature.
Stamatakos M; Fyllos A; Siafogianni A; Ntzeros K; Tasiopoulou G; Rozis M; Kontzoglou K
J BUON; 2014; 19(1):34-41. PubMed ID: 24659640
[TBL] [Abstract][Full Text] [Related]
23. Dermatofibrosarcoma Protuberans Re-excision and Recurrence Rates in the Netherlands Between 1989 and 2016.
van Lee CB; Kan WC; Gran S; Mooyaart A; Mureau MAM; Williams HC; Matin R; van den Bos R; Hollestein LM
Acta Derm Venereol; 2019 Nov; 99(12):1160-1165. PubMed ID: 31410492
[TBL] [Abstract][Full Text] [Related]
24. Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy.
Castle KO; Guadagnolo BA; Tsai CJ; Feig BW; Zagars GK
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):585-90. PubMed ID: 23628134
[TBL] [Abstract][Full Text] [Related]
25. Conservative Re-excision is a Safe and Simple Alternative to Radical Resection in Revision Surgery for Dermatofibrosarcoma Protuberans.
Snow H; Davies E; Strauss DC; Smith M; Hayes AJ
Ann Surg Oncol; 2020 Mar; 27(3):919-923. PubMed ID: 31664620
[TBL] [Abstract][Full Text] [Related]
26. Mohs micrographic surgery for dermatofibrosarcoma protuberans: University of Miami and NYU experience.
Nouri K; Lodha R; Jimenez G; Robins P
Dermatol Surg; 2002 Nov; 28(11):1060-4; discussion 1064. PubMed ID: 12460303
[TBL] [Abstract][Full Text] [Related]
27. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.
Liang CA; Jambusaria-Pahlajani A; Karia PS; Elenitsas R; Zhang PD; Schmults CD
J Am Acad Dermatol; 2014 Oct; 71(4):781-6. PubMed ID: 24755121
[TBL] [Abstract][Full Text] [Related]
28. Transformed dermatofibrosarcoma protuberans: a clinicopathological study of eight cases.
Szollosi Z; Nemes Z
J Clin Pathol; 2005 Jul; 58(7):751-6. PubMed ID: 15976346
[TBL] [Abstract][Full Text] [Related]
29. Dermatofibrosarcoma protuberans in children and adolescents: The European Paediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005).
Brennan B; Zanetti I; De Salvo GL; Orbach D; Gallego S; Francotte N; Schifflers S; Van Noesel M; Kelsey A; Casanova M; Dagrada GP; Collini P; Zin A; Santoro L; Ferrari A
Pediatr Blood Cancer; 2020 Oct; 67(10):e28351. PubMed ID: 32558231
[TBL] [Abstract][Full Text] [Related]
30. Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatment.
Stojadinovic A; Hoos A; Karpoff HM; Leung DH; Antonescu CR; Brennan MF; Lewis JJ
Arch Surg; 2001 Jan; 136(1):70-9. PubMed ID: 11146782
[TBL] [Abstract][Full Text] [Related]
31. Dermatofibrosarcoma protuberans: review of 20-years experience.
Ruiz-Tovar J; Fernández Guarino M; Reguero Callejas ME; Aguilera Velardo A; Arano Bermejo J; Cabañas Navarro L
Clin Transl Oncol; 2006 Aug; 8(8):606-10. PubMed ID: 16952850
[TBL] [Abstract][Full Text] [Related]
32. Mohs micrographic surgery and dermatofibrosarcoma protuberans: a multidisciplinary approach in 44 patients.
Nelson RA; Arlette JP
Ann Plast Surg; 2008 Jun; 60(6):667-72. PubMed ID: 18520205
[TBL] [Abstract][Full Text] [Related]
33. Dermatofibrosarcoma Protuberans: A Clinicopathologic and Therapeutic Analysis of 254 Cases at a Single Institution.
Jing C; Zhang H; Zhang X; Yu S
Dermatol Surg; 2021 Feb; 47(2):e26-e30. PubMed ID: 32769521
[TBL] [Abstract][Full Text] [Related]
34. Dermatofibrosarcoma protuberans: surgical management of a challenging mesenchymal tumor.
Wiesmueller F; Agaimy A; Perrakis A; Arkudas A; Horch RE; Grützmann R; Vassos N
World J Surg Oncol; 2019 May; 17(1):90. PubMed ID: 31138233
[TBL] [Abstract][Full Text] [Related]
35. 3D-Histological evaluation of surgery in dermatofibrosarcoma protuberans and malignant fibrous histiocytoma: differences in growth patterns and outcome.
Häfner HM; Moehrle M; Eder S; Trilling B; Röcken M; Breuninger H
Eur J Surg Oncol; 2008 Jun; 34(6):680-6. PubMed ID: 17716851
[TBL] [Abstract][Full Text] [Related]
36. Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinico-pathologic and immunohistochemic study in four cases.
Díaz-Cascajo C; Weyers W; Borrego L; Iñarrea JB; Borghi S
Am J Dermatopathol; 1997 Dec; 19(6):562-7. PubMed ID: 9415611
[TBL] [Abstract][Full Text] [Related]
37. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
[TBL] [Abstract][Full Text] [Related]
38. The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans.
Adem D; Yazici S; Ozsen M; Cetintas SK; Yalcinkaya U; Şahin AB; Tanrıverdi O; Orhan SO; Ocak B; Cubukcu E; Kahveci R; Evrensel T
Bosn J Basic Med Sci; 2021 Apr; 21(2):174-178. PubMed ID: 33091330
[TBL] [Abstract][Full Text] [Related]
39. Clinical and pathological analysis of dermatofibrosarcoma protuberans with long-term follow-up.
Shi X; Tan Q
J Plast Reconstr Aesthet Surg; 2020 Jun; 73(6):1143-1150. PubMed ID: 32201322
[TBL] [Abstract][Full Text] [Related]
40. [Myxoid dermatofibrosarcoma protuberans: a clinicopathologic analysis of 16 cases].
Ren WM; Sheng WQ; Wang J
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):456-60. PubMed ID: 22932456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
